"Designing Growth Strategies is in our DNA"

U.S. Ventricular Assist Devices Market Size, Share & Industry Analysis, By Product (Left Ventricular Assist Device, Right Ventricular Assist Device, and Bi-Ventricular Assist Device), By Type (Pulsatile Flow and Continuous Flow), By Application (Bridge to Transplant (BTT), Bridge to Candidacy (BTC), Destination Therapy (DT), and Bridge to Recovery (BTR)), and By End-user (Hospitals & ASCs and Specialty Clinics & Others), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107850

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 9.7% from 2024 to 2032

Unit

Value (USD Million)

Segmentation

By Product

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Bi-Ventricular Assist Device

By Type of Flow

  • Pulsatile Flow
  • Continuous Flow

By Application

  • Bridge to Transplant (BTT)
  • Bridge to Candidacy (BTC)
  • Destination Therapy (DT)
  • Bridge to Recovery (BTR)

By End-user

  • Hospitals & ASCs
  • Specialty Clinics & Others
  • 2019-2032
  • 2023
  • 2019-2022
  • 0
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann